Direxion Daily S&P Biotech Bear 3X Shares
LABD
LABD
18 hedge funds and large institutions have $16.2M invested in Direxion Daily S&P Biotech Bear 3X Shares in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
44% less capital invested
Capital invested by funds: $28.7M → $16.2M (-$12.5M)
Holders
18
Holding in Top 10
–
Calls
$7.69M
Puts
$1.04M
Top Buyers
| 1 | +$5.39M | |
| 2 | +$1.13M | |
| 3 | +$511K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$444K |
| 5 |
HT
Headlands Technologies
Chicago,
Illinois
|
+$420K |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$5.55M | |
| 3 | -$509K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$461K |
| 5 |
GS
GTS Securities
New York
|
-$354K |